Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 17;66(6):883-894.
doi: 10.20945/2359-3997000000479. Epub 2022 Jun 2.

Flash glucose monitoring system in special situations

Affiliations
Review

Flash glucose monitoring system in special situations

Fernanda Augustini Rigon et al. Arch Endocrinol Metab. .

Abstract

The management of diabetes mellitus (DM) requires maintaining glycemic control, and patients must keep their blood glucose levels close to the normal range to reduce the risk of microvascular complications and cardiovascular events. While glycated hemoglobin (A1C) is currently the primary measure for glucose management and a key marker for long-term complications, it does not provide information on acute glycemic excursions and overall glycemic variability. These limitations may even be higher in some special situations, thereby compromising A1C accuracy, especially when wider glycemic variability is expected and/or when the glycemic goal is more stringent. To attain adequate glycemic control, continuous glucose monitoring (CGM) is more useful than self-monitoring of blood glucose (SMBG), as it is more convenient and provides a greater amount of data. Flash Glucose Monitoring (isCGM /FGM) is a widely accepted option of CGM for measuring interstitial glucose levels in individuals with DM. However, its application under special conditions, such as pregnancy, patients on hemodialysis, patients with cirrhosis, during hospitalization in the intensive care unit and during physical exercise has not yet been fully validated. This review addresses some of these specific situations in which hypoglycemia should be avoided, or in pregnancy, where strict glycemic control is essential, and the application of isCGM/FGM could alleviate the shortcomings associated with poor glucose control or high glycemic variability, thereby contributing to high-quality care.

Keywords: Diabetes mellitus; blood glucose self-monitoring; liver cirrhosis; pregnancy; renal dialysis.

PubMed Disclaimer

Conflict of interest statement

Disclosure: no potential conflict of interest relevant to this article was reported.

Figures

Figure 1
Figure 1. Example of an ambulatory glucose profile report, a standardized single-page report developed by the International Diabetes Center and adopted by most of the CGM device manufacturers, including 14 days of data. The middle graph shows the median glucose over 24 hours and its variation (5th, 25th, 75th, and 95th percentile), while the bottom graph shows daily glucose profiles. The stacked bar graph at the top right corner displays the percentage of time spent within, below, and above the target range. The additional table at the top left corner describes glucose statistics and targets.

Similar articles

Cited by

References

    1. Hirsch IB. Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does! Diabetes Care. 2015;38(8):1610–1614. - PubMed
    1. Garber AJ, Handelsman Y, Grunberger G, Einhorn D, Abrahamson MJ, Barzilay JI, et al. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary. Endocr Pract. 2020;26(1):107–139. - PubMed
    1. Beyond A1C Writing Group Need for Regulatory Change to Incorporate Beyond A1C Glycemic Metrics. Diabetes Care. 2018;41(6):e92–e94. - PubMed
    1. Bry L, Chen PC, Sacks DB. Effects of Hemoglobin Variants and Chemically Modified Derivatives on Assays for Glycohemoglobin. Clin Chem. 2001;47(2):153–163. - PubMed
    1. Shi T, Li D, Li G, Zhang Y, Xu K, Lu L. Modeling and Measurement of Correlation between Blood and Interstitial Glucose Changes. J Diabetes Res. 2016;2016:1–9. - PMC - PubMed

LinkOut - more resources